Valuation: CStone Pharmaceuticals

Market Cap 6.26B 7.24B 923M 807M 745M 686M 1.29B 88.93B 1.32B 8.9B 3.5B 43.55B 3.47B 3.39B 150B P/E 2026 *
-294x
P/E 2027 * 5.85x
Enterprise Value 5.73B 6.63B 846M 739M 682M 628M 1.18B 81.42B 1.21B 8.15B 3.21B 39.88B 3.18B 3.11B 137B EV / Sales 2026 *
12x
EV / Sales 2027 * 1.55x
Free-Float
77.71%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: CStone Pharmaceuticals

1 day+3.31%
1 week-5.45%
Current month-0.64%
1 month-0.43%
3 months-54.03%
6 months-14.60%
Current year-11.20%
1 week 4.5
Extreme 4.5
5.37
1 month 4.25
Extreme 4.25
5.79
Current year 4.01
Extreme 4.01
10.41
1 year 4.01
Extreme 4.01
13.15
3 years 0.8
Extreme 0.8
13.15
5 years 0.8
Extreme 0.8
17.54
10 years 0.8
Extreme 0.8
19.12
Manager TitleAgeSince
Chief Executive Officer 62 2022-08-24
Director of Finance/CFO - 2023-01-17
Chief Operating Officer 46 2016-07-31
Director TitleAgeSince
Chairman 55 -
Director/Board Member 62 2022-08-24
Director/Board Member 63 2021-07-08
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Other

Chief Executive Officer

331,000 0.0207%
6/23/26 Other

Chief Executive Officer

11,270,000 0.7043%
6/12/26 Other

Director

150,000 0.0094%
Change 5-day change 1-year change 3-year change Capi.($)
+3.31%-5.45%-28.33%+96.64% 923M
-0.33%+1.83%+24.73%-5.89% 68.85B
-0.42%+1.15%+37.51%+190.33% 52.13B
+0.94%+39.60%+39.60%+39.60% 43.46B
-0.58%+1.05%-51.98%-53.78% 41.24B
-1.40%+3.43%+64.81%-25.61% 30.41B
-2.11%-9.45%+97.76%-50.61% 24.53B
+0.51%+0.46%+72.78%+86.41% 23.42B
+3.99%+3.82%+4.34%+196.00% 19.75B
-1.08%-0.95%+69.81%+123.48% 16.57B
Average +0.28%-1.94%+33.10%+59.66% 32.13B
Weighted average by Cap. -0.14%+0.04%+32.76%+46.78%

Financials

2026 *2027 *
Net sales 479M 554M 70.71M 61.8M 57.02M 52.56M 99.07M 6.81B 101M 682M 268M 3.34B 266M 260M 11.48B 1.71B 1.98B 253M 221M 204M 188M 354M 24.34B 362M 2.44B 958M 11.92B 949M 928M 41.04B
Net income -243M -281M -35.88M -31.36M -28.93M -26.67M -50.27M -3.46B -51.38M -346M -136M -1.69B -135M -132M -5.83B 687M 795M 101M 88.63M 81.79M 75.39M 142M 9.77B 145M 978M 384M 4.78B 381M 373M 16.47B
Net Debt -528M -611M -77.93M -68.1M -62.84M -57.92M -109M -7.5B -112M -751M -295M -3.68B -293M -286M -12.65B -3.6B -4.17B -532M -465M -429M -395M -745M -51.19B -761M -5.12B -2.02B -25.07B -2B -1.95B -86.31B
Logo CStone Pharmaceuticals
CStone Pharmaceuticals is an investment holding company primarily engaged in research and development of therapies for oncology, autoimmune and inflammation, and other key disease areas. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, the sales of pharmaceutical products, as well as the provision of license of its intellectual property (IP) or commercialization license. The Company’s products primarily include targeted therapies, AYVAKIT (avapritinib), GAVRETO (pralsetinib) and CEJEMLY (sugemalimab). The Company is also engaged in the development and commercialization of immuno-oncology. The Company primarily conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.
Employees
136
Date Price Change Volume
26-07-20 HK$4.680 +3.31% 10,171,000
26-07-17 HK$4.530 -12.55% 12,204,000
26-07-16 HK$5.180 +0.19% 5,882,500
26-07-15 HK$5.170 +5.08% 7,980,270
26-07-14 HK$4.920 -0.61% 4,395,700
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.916CNY
Average target price
12.38CNY
Spread / Average Target
+216.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2616 Stock